BML-277 is primarily utilized in research settings to study cellular processes and signaling pathways. It is a potent and selective inhibitor of ATM kinase, making it a valuable tool for investigating the role of this enzyme in DNA damage response, cell cycle control, and DNA repair. Researchers use it to explore mechanisms related to cell proliferation, apoptosis, and DNA damage response. Its application extends to cancer research, where it helps in understanding tumor growth and identifying potential therapeutic targets. Additionally, BML-277 is employed in pharmacological studies to assess its efficacy and safety profile for potential drug development.